Arrowhead Pharmaceuticals
ARWR
#1823
Rank
S$15.27 B
Marketcap
S$108.46
Share price
4.41%
Change (1 day)
407.03%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - P/B ratio

P/B ratio as of July 2026 : 19.8

According to Arrowhead Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 10.844.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Arrowhead Pharmaceuticals - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-3116.7-60.41%
2024-12-3142.1122.32%
2023-12-3118.962.49%
2022-12-3111.6-37.39%
2021-12-3118.67.22%
2020-12-3117.335.12%
2019-12-3112.891.47%
2018-12-316.7170.94%
2017-12-313.92231.67%
2016-12-311.18-70.21%
2015-12-313.9743.26%
2014-12-312.77-47.01%
2013-12-315.2318.8%
2012-12-314.4057.21%
2011-12-312.80-68.24%
2010-12-318.8273.56%
2009-12-315.08-35.68%
2008-12-317.9050.5%
2007-12-315.2516.85%
2006-12-314.49-23.12%
2005-12-315.84-7.34%
2004-12-316.3112481.19%
2003-12-310.0501-352.71%
2002-12-31-0.0198

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.80-60.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
4.27-78.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
6.42-67.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
38.8 96.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-13.0-165.82%๐Ÿ‡บ๐Ÿ‡ธ USA